These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3774084)

  • 21. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency.
    Chandna SM; Kulinskaya E; Farrington K
    Nephrol Dial Transplant; 2005 Oct; 20(10):2130-8. PubMed ID: 15956057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative evaluation of cuprophane and cellophane used as membranes for hemodialysis].
    Rudman AR; Vengerova NA; El'tsefon BS
    Med Tekh; 1976; (4):31-5. PubMed ID: 1025438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
    Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a blood purification system for renal failure rats using small-size dialyzer membranes.
    Yorimitsu D; Satoh M; Koremoto M; Haruna Y; Nagasu H; Kuwabara A; Sasaki T; Kashihara N
    Ther Apher Dial; 2012 Dec; 16(6):566-72. PubMed ID: 23190517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of the possibility of multiple use of capillary dialyzers. II. Effectiveness of the elimination of urea and creatinine].
    Szepietowski T; Uzar J
    Polim Med; 1986; 16(3-4):123-35. PubMed ID: 3588428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemofiltration, an alternative method for treatment of end-stage renal failure.
    Man NK; Funck-Brentano JL
    Adv Nephrol Necker Hosp; 1977; 7():293-310. PubMed ID: 96676
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of 3 high-permeability dialysers].
    Montagnac R; Schillinger F; Milcent T; Cheriot J; Dupoirieux J; Turret MM; Manceaux JC
    Nephrologie; 1987; 8(5):257-9. PubMed ID: 3328103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behaviour of clearances and diffusive permeability during hemodialysis with PMMA dialyzers: clinical study.
    Ghezzi PM; Canepari G; Ronco C
    Contrib Nephrol; 1999; 125():53-64. PubMed ID: 9895430
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrin deposition in disposable dialyzers before and after re-use.
    Gunnarsson B; Asaba H; Kiibus A; Söderborg B; Wiklund S; Bergström J
    Clin Nephrol; 1979 Sep; 12(3):117-21. PubMed ID: 509786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Single-needle dialysis. Experiences at the Kidney Transplant Unit of the Clinical Hospital of the University of São Paulo Medical School].
    Massola VC; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Dec; 33(6):268-71. PubMed ID: 746289
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ultraviolet spectrophotomerty studies of serum dialysate from patients with long term intermittent artificial kidney treatment].
    Boda D; Gál G; Eck E; Kiss E
    Z Urol Nephrol; 1977 May; 70(5):345-9. PubMed ID: 408997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implantable artificial kidney.
    Fissell WH; Roy S
    Semin Dial; 2009; 22(6):665-70. PubMed ID: 20017839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the effects of low dialysate flow rates on removal rates and clearance using high flux membranes.
    Park KI; Tomoyoshi T
    Blood Purif; 1997; 15(3):208-12. PubMed ID: 9262848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysate regeneration: 30-liter dialysate supply system with sorbents.
    Maeda K; Ohta K; Manji T; Saito A; Kawaguchi S
    Kidney Int Suppl; 1976 Dec; (7):S289-95. PubMed ID: 1070549
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.
    Meyer TW; Leeper EC; Bartlett DW; Depner TA; Lit YZ; Robertson CR; Hostetter TH
    J Am Soc Nephrol; 2004 Jul; 15(7):1927-35. PubMed ID: 15213283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.